Skip to main content
2023 IKCS: North America Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Novel Immunotherapy in Early Phase Clinical Development for RCC

Saturday, November 11, 2023
9:50 AM – 10:00 AM CST

    Speaker(s)

  • Vivek Narayan, MD, MSCE

    University of Pennsylvania
    University of Pennsylvania, Pennsylvania, United States

    Disclosure(s): Non-CE Consulting: Bristol Meyers Squibb (Terminated); Exelixis (Terminated); Janssen (Terminated); Merck (Terminated); Pfizer (Terminated); Regeneron (Terminated)

    Slides
Disclosure(s):
Vivek Narayan: Non-CE Consulting: Bristol Meyers Squibb (Terminated); Exelixis (Terminated); Janssen (Terminated); Merck (Terminated); Pfizer (Terminated); Regeneron (Terminated)